These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8032242)

  • 1. The importance of antigenic variation in vaccine design.
    Brown F
    Arch Virol Suppl; 1994; 9():1-8. PubMed ID: 8032242
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain.
    González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F
    Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production.
    Piatti P; Hassard S; Newman JF; Brown F
    Vaccine; 1995; 13(8):781-4. PubMed ID: 7483796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus.
    Martinez MA; Carrillo C; Plana J; Mascarella R; Bergada J; Palma EL; Domingo E; Sobrino F
    Gene; 1988; 62(1):75-84. PubMed ID: 2453395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi RD; Little SP; Gale C
    Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging foot-and-mouth disease virus variants with antigenically critical amino acid substitutions predicted by model studies using reference viruses.
    Feigelstock DA; Mateu MG; Valero ML; Andreu D; Domingo E; Palma EL
    Vaccine; 1996 Feb; 14(2):97-102. PubMed ID: 8852403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
    Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
    Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
    Tulasiram P; Suryanarayana V
    Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular characterization of aphthous fever virus isolated during the years 1993-1994 in Argentina].
    König G; Blanco C; Feigelstock D; Chimeno Zoth S; Pereda A; Palma EL; Maradei E; Piccone ME
    Rev Argent Microbiol; 2001; 33(2):81-8. PubMed ID: 11494760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide sequence of the P1 region of serotype Asia1 foot-and-mouth disease virus.
    Stram Y; Laor O; Molad T; Chai D; Moore D; Yadin H; Becker Y
    Virus Genes; 1994 Jul; 8(3):275-8. PubMed ID: 7975273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus.
    van Rensburg HG; Nel LH
    Virus Genes; 1999; 19(3):229-33. PubMed ID: 10595414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic variation in Foot and Mouth Disease Virus type Asia 1 isolates circulated during 1993-95 in India.
    Tulasiram P; Tyagi M; Srinivas K; Prabhudas K; Natarajan C; Suryanarayana V
    Virus Genes; 1997; 15(3):247-53. PubMed ID: 9482590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus.
    Martín MJ; Núñez JI; Sobrino F; Dopazo J
    J Virol Methods; 1998 Oct; 74(2):215-21. PubMed ID: 9779622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sources of variations encountered during the selection and production of three strains of FMD virus for the development of vaccine for use in Nigeria.
    Preston KJ; Owens H; Mowat GN
    J Biol Stand; 1982 Jan; 10(1):35-45. PubMed ID: 6279666
    [No Abstract]   [Full Text] [Related]  

  • 17. Display-induced antigenic variation in recombinant peptides.
    Carbonell X; Feliu JX; Benito A; Villaverde A
    Biochem Biophys Res Commun; 1998 Jul; 248(3):773-7. PubMed ID: 9704003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
    Vol'pina OM; Surovoi AYu ; Ivanov VT
    Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.
    Kit M; Kit S; Little SP; Di Marchi RD; Gale C
    Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).
    Sobrino F; Martinez MA; Carrillo C; Beck E
    Virus Res; 1989 Dec; 14(4):273-80. PubMed ID: 2560293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.